MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202647076036 A) filed by Aurigene Oncology Limited on June 19, 2026, for Macrocyclic Compounds As Kif18a Inhibitors.
Inventors include Abbineni, Chandrasekhar; Kadam, Vijay; Sengupta, Sandip; Samajdar, Susanta; Simonovich, Scott; Gillespie, Paul; M. Green, Evan; and Sanders, John.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The present disclosure provides macrocyclic compounds of formula (I), which are therapeutically useful as KIF18A inhibitors.(I) These compounds are useful in the treatment and/or prevention of diseases and/or disorders responsive to the inhibition of KIF18A activity. Compounds...